万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://www.karger.com/Journal/Home/224036
3、投稿网址：
https://www.manuscriptmanager.net/HRP?product_id=224036
4、官网邮箱：hrp@karger.com
5、官网电话：+41 61 306 1437
6、期刊刊期：月刊，一年出版12期。
2021年7月30日星期五
投稿须知【官网信息】
Hormone Research in Paediatrics
Author Guidelines
About the Journal
Aims and Scope
The mission of Hormone Research in Paediatrics is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini-reviews, clinical guidelines or novel insights from clinical practice, and abstracts from international congresses in pediatric endocrinology. Periodic editorials from outstanding pediatric endocrinologists also address contemporary research by critically reviewing the major strengths and weaknesses of the studies. Hormone Research in Paediatrics is the official journal of the European Society for Paediatric Endocrinology, Pediatric Endocrine Society, and Sociedade Latino-Americana de Endocrinologia Pediátrica.
Journal Sections
Invited Mini Reviews
Hormone Research in Paediatrics publishes one or two focused mini reviews in each issue. These mini reviews are aimed at covering a wide range of basic and clinical topics, of interest for its readership. Hormone Research in Paediatrics mini reviews are available to non-subscribers in free access on the web.
Target audience: Hormone Research in Paediatrics readership is composed mainly of pediatric endocrinologists and endocrinologists, dealing with clinical, clinical research or basic research activities. The mini reviews are intended mostly for a clinical readership who may not read the primary literature on basic mechanisms of endocrine diseases, neurosciences and methodological aspects. Therefore, reviewers should avoid technical jargon to increase the accessibility of the text for a general audience.
Contents: Reviews on basic science topics should include clinical applications or clinical perspectives (approx. 1/4th to 1/5th of the manuscript). Conversely, reviews of clinical topics should discuss basic mechanisms relevant to the topic (approx. 1/4th to 1/5th of the manuscript).
Format: The mini review should be about 3,000 words, not including the references. There should be an abstract of no more than 200 words as well as approximately 5 key words. The manuscript should be organized with headings and subheadings to improve readability. Figures: A maximum of 5 figures may be included. They should be prepared with great care and should be self-explanatory. References: There should be a maximum of 60 references.
Copyright: The authors should state whether they have a similar review in press or in preparation and if so send a copy or an outline of the other review to avoid duplicate publication.
Submission: Most mini reviews are commissioned by the editorial board. However, unsolicited mini reviews are welcome. It is suggested, however, to contact the Editorial Office before submission.
New Techniques in Paediatric Endocrinology
Historical contributions
Target audience: Hormone Research in Paediatrics readership is composed mainly of pediatric endocrinologists and endocrinologists dealing with clinical, clinical research or basic research. Contributions to the History Section may review the discovery, development, and history of a hormone, drug or other factor relevant to endocrinology, an endocrine organ, system or disorder, or the contributions of a major endocrine scientist or group of scientists and clinicians. Reproduction of classic or obscure ancient publications that may not be available through standard indexing services, including translation and commentary, are appropriate for the History Section.
Contents: Historical contributions may be written in whatever format that the author believes best tells an interesting and informative story or vignette from history, but should generally include a presentation of the background, the work or discovery being reviewed, and ist relevance to contemporary pediatric endocrinology.
Copyright: The authors must state whether they have a similar review in press or in preparation and if so send a copy or an outline of the other review to avoid duplicate publication.
Submission: Most Historical contributions are commissioned by the editorial board. However, unsolicited contributions are welcome. It is suggested, however, to contact the Editorial Office first.
Clinical Practice Committee Publication
Novel Insights from Clinical Practice
Consensus Statement
Article Types
Research Article
Research Articles report on primary research. They must describe significant and original observations. Consideration for publication is based on the article’s originality, novelty, and scientific soundness, and the appropriateness of its analysis.
Research Articles are reports of original work. Authors are asked to follow the EQUATOR Network for Research Articles.
Prior approval from an Institutional Review Board (IRB) or an Ethics Review Committee is required for all investigations involving human subjects.
A downloadable template is available below.
Documents
Research Article (DOCX, 28.97 KB)
Any research articles on hormone research are accepted; we particularly welcome papers on developmental and clinical research. The length of abstract should be 250 words.
Review Article
Review Articles are considered reviews of research or summary articles. They are state-of-the-art papers covering a current topic by experts in the field. They should give evidence on and provide answers to a well-defined aspect or question in a particular area. Review Articles must include a critical discussion of the reported data and give a clear conclusion with potential impacts on the standard of care.
A downloadable template is available below.
Documents
Review Article (DOCX, 23.66 KB)
Invited Mini Review (DOCX, 23.86 KB)
Authors may wish to submit one of the following Review Articles:
Standard Review Article: Review articles should contain up to 3,000 words, including a 200-word abstract, 5 figures and up to 60 references.
Mini Reviews: For "Invited Mini Reviews" please see the provided template.
Case Report
Case Reports can present a case study, case report, or other description of a case. Case Reports present significant new insights or cases with an unusual and noteworthy course. Submissions can be based on a case or a number of similar cases. The most important aspect of the presentation is that it should provide a new perspective on a recognized clinical scenario or may represent an entirely new clinical condition. The novelty of the case(s) may lie in the phenotype, the presentation, the investigation, and/or the management. We strongly encourage authors to comply with the CARE guidelines.The manuscript must include a statement detailing that written informed consent for publication was obtained and from whom (e.g. “Written informed consent was obtained from the patient for publication of this case report and any accompanying images.”). If the patient has died, consent for publication must be obtained from their next of kin. If the patient described in the case report is a minor or vulnerable, then consent for publication must be obtained from the parent/legal guardian. The completed consent form must be made available to the Editor if requested, and will be treated confidentially.
A downloadable template is available below.
Documents
Novel Insights (DOCX, 27.75 KB)
Authors may wish to submit the following Case Report:
Novel Insights: This Case Report is to include highlighted boxes containing one or two bullet points on 'Established Facts' (what is already known) and 'Novel Insights' (what new information has been gained). These should be selected so as to reinforce the novelty of the clinical observation.
Brief Report
Brief Reports are short and/or rapid announcements of research results. They must contain data derived from cutting-edge research and be of potential interest to a large proportion of the readership. They are independent, concise reports representing a significant contribution to the field. Such communications should represent complete, original studies and should be arranged in the same way as full-length manuscripts with subheadings.
A downloadable template is available below.
Documents
Brief Report (DOCX, 27.12 KB)
Brief reports should contain up to 1200 words, max 2 figures, and 12 references.
Commentary
Commentaries draw attention to a jointly published article, discussing the context or implications of the article and highlighting points of wider relevance to the field. Commentaries are presented from the author’s perspective and do not include original data. Commentaries are invited by the Editors and relate to an article in the same issue.
A downloadable template is available below.
Documents
Commentary (DOCX, 23.56 KB)
Editorial
Editorials provide a viewpoint on specific articles or on general subjects directly relevant to the journal. Editorials are written by an editor or other member of the journal.
A downloadable template is available below.
Documents
Editorial (DOCX, 24.95 KB)
Letter
Letters may explore subjects related to matters discussed in the journal, providing the author’s perspective on a subject. Letters may discuss a recently published article and may lend support or constructively critique the article in line with the author’s experience. The editors reserve the right to share such letters to the authors of the article concerned prior to publication in order to permit response, ideally in the same issue of the journal. Letters should not include original data.
A downloadable template is available below.
Documents
Letter (DOCX, 24.24 KB)
Guidelines
Guidelines are statements intended to guide clinical care. They should describe the clinical problem to be addressed, the mechanism by which the statement was generated, a review of the evidence for the statement and the statement on practice itself.
A downloadable template is available below.
Documents
Guidelines (DOCX, 24.69 KB)
Contact Information
Should you have any problems with your submission, please contact the editorial office:
Manuela Obrist
Editorial Office 'Hormone Research in Paediatrics'
S. Karger AG
P.O. Box
CH–4009 Basel (Switzerland)
Tel. +41 61 306 1437
Fax +41 61 306 1434
hrp@karger.com
Editorial and Journal Policies
General Conditions
Only papers written in English are considered. The articles should be comprehensible to a reader who is fluent in English and should be edited prior to submission to ensure that standard English grammar and usage are observed. Use of a professional language editing service prior to submission can help avoid delays with the review process.
All manuscripts are subject to editorial review.
The presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE).
Karger journals aim to adhere to the COPE Code of Conduct and Best Practice Guidelines.
By submitting an article for publication, the authors agree to the transfer of the copyright to the publisher upon acceptance. Accepted papers become the permanent property of the Journal and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.
The Submission Statement with original (hand-written) signatures is to be provided upon submitting the paper. If it is not possible to collect all signatures on a single document, individual copies should be provided for each author.
Karger recommends the use of original images and materials whenever possible. If a submitted manuscript contains third-party copyright material(s), it is the authors’ sole responsibility to obtain permission from the relevant copyright holder for reusing the material(s), including any associated licensing fee. The copyright and usage information needs to be checked carefully to avoid copyright infringement.
Most publishers offer a quick and easy way to clear permissions for their content via the built-in website application RightsLink or via https://www.copyright.com/get-permissions/. Another widely used licensing tool is PLSClear. Please check the publishers’ websites for the available options and user instructions.
Statements
All submitted manuscripts must contain a statements section after the main body of the text, but before the reference list.
Statement of Ethics
Published research must comply with internationally-accepted standards for research practice and reporting. Manuscripts may be rejected if the editors believe that the research has not been carried out within an appropriate ethical framework, and concerns raised after publication may lead to a correction, retraction, or expression of concern in line with COPE guidelines.
Studies involving human subjects (including research on identifiable human material and data) must have been performed with the approval of an appropriate ethics committee and with appropriate participants’ informed consent in compliance with the Helsinki Declaration.
In the manuscript, authors should specify the name of the ethics committee or other relevant authority who approved the study protocol and provide the reference number where appropriate. If ethics approval was not required, or if the study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee who made that decision).
For all research involving human subjects, written informed consent to participate in the study should be obtained from participants (or their parent/legal guardian where appropriate ) and a statement detailing this should appear in the manuscript. For studies involving vulnerable participants or participants at risk of potential coercion, detailed information regarding the steps taken to ensure informed consent must be provided. If consent was not obtained, please specify why and whether this was approved by the ethics committee.
In line with the ICMJE recommendations on the protection of research participants, authors must avoid providing identifying information unless strictly necessary for the submission and participants’ identifiable attributes must be anonymized in the manuscript and its supplementary files, if any. If identifying information is necessary, authors must confirm that the individual has provided written consent for the use of that information in a publication.
Research involving human embryonic stem cells, embryonic germ cells or induced pluripotent stem cells should comply with the ISSCR 'Guidelines for the Conduct of Human Embryonic Stem Cell Research' or an equivalent set of guidelines or applicable regulations.
……
更多详情：
https://www.karger.com/Journal/Guidelines/224036
